InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Interest Income - Total (2017 - 2026)

InflaRx's (IFRX) quarterly Interest Income - Total came in at $4.2 million in Q2 2026, up 146.55% year-over-year from $1.7 million in Q2 2025, and up 321.09% quarter-over-quarter from -$1.9 million in Q1 2026.

Analysis

InflaRx (IFRX) Interest Income - Total (2017 - 2026) Analysis & Trends

InflaRx has disclosed Interest Income - Total across 9 years of filings, most recently posting $4.2 million for Q2 2026.

  • In Q2 2026, Interest Income - Total rose 146.55% year-over-year to $4.2 million; the TTM figure through Jun 2026 stood at $3.0 million (up 149.83% YoY), while the FY2025 annual figure was -$3.0 million, up 59.87% from the prior year.
  • Interest Income - Total came in at $4.2 million for Q2 2026 at InflaRx, up from -$1.9 million in the prior quarter.
  • In the past five years, Interest Income - Total ranged from a high of $4.2 million in Q2 2026 to a low of -$5.0 million in Q4 2024.
  • Average Interest Income - Total over 5 years is -$730977.4, with a median of -$1.3 million recorded in 2022.
  • Year-over-year, Interest Income - Total soared 744.55% in 2023 and slumped 686.06% in 2024.
  • Over 5 years, Interest Income - Total stood at $334283.0 in 2022, then soared by 744.55% to $2.8 million in 2023, then tumbled by 276.07% to -$5.0 million in 2024, then soared by 48.09% to -$2.6 million in 2025, then surged by 262.04% to $4.2 million in 2026.
  • Per Business Quant data, the three most recent Interest Income - Total figures were $4.2 million in Q2 2026, -$1.9 million in Q1 2026, and -$2.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Income - Total (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn 4.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.18 Mn
Jun 30, 2026 4.18 Mn
Mar 31, 2026 -1.89 Mn
Mar 31, 2026 -1.89 Mn
Dec 31, 2025 -2.58 Mn
Dec 31, 2025 -2.58 Mn
Sep 30, 2025 3.24 Mn
Sep 30, 2025 3.24 Mn
Jun 30, 2025 1.70 Mn
Jun 30, 2025 1.70 Mn
Mar 31, 2025 -4.93 Mn
Mar 31, 2025 -4.93 Mn
Dec 31, 2024 -4.97 Mn
Dec 31, 2024 -4.97 Mn
Sep 30, 2024 2.29 Mn
Sep 30, 2024 2.29 Mn
Jun 30, 2024 -1.67 Mn
Jun 30, 2024 -1.67 Mn
Mar 31, 2024 -3.08 Mn
Mar 31, 2024 -3.08 Mn